Attention deficit/hyperactivity disorder
Conditions
Interventions
Single administration of methylphenidate
Single administration of placebo
Sponsors
University of Fukui, Research Center for Child Mental Development, Division of Psychosocial Support for Nurturing
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with attention-deficit/hyperactivity disorder based on the classifications in the diagnostic and statistical manual of mental disorders (DSM-5). 2) Subjects within the age range of 6-17 years old. 3) Must demonstrate an acceptable degree of compliance with medication and procedures in the opinion of the investigator.
Exclusion criteria
Exclusion criteria: 1) History of allergy for methylphenidate. 2) Subjects who have any other current DSM-5 diagnosis of the following; "schizophrenia", "substance-related disorders", "eating disorders", "personality disorders". 3) Subjects who have a physical disorder with a need of strict diet, or a diagnosis of a severe physical disorder. 4) Women who are breastfeeding, pregnant, possibility of pregnancy, or have a wish of early pregnancy. 5) Subjects with metalic device in their body. 6) Subjects who, in the Investigator's opinion, might not be suitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resting state fMRI analysis: Comparison of brain function after methylphenidate or placebo administration. | — |
Secondary
| Measure | Time frame |
|---|---|
| Neuropsychological test | — |
Countries
Japan
Contacts
Public ContactTomoda Akemi
University of Fukui, Research Center for Child Mental Development Division of Psychosocial Support for Nurturing
Outcome results
None listed